Sort
50,496 grants matching “lung cancer”
Tumor selective inhibition of the WNT pathway
$568,218Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Developmental pathways regulating adult lung quiescence
$568,206Edward E Morrisey · University Of Pennsylvania · R01 · FY2016 · HL
Therapeutic agents targeting nuclear receptor signaling in distinct molecular subtypes of breast cancer
$568,179Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2019 · CA
Structural and functional principles of activation and regulation of the transient receptor potential channel TRPV3.
$568,116Alexander Sobolevsky · Columbia University Health Sciences · R01 · FY2024 · AR
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
$568,064Kevan C Herold · Yale University · R01 · FY2019 · CA
Web-based Smoking Cessation Program for Tribal College Students
$568,026Won S Choi · University Of Kansas Medical Center · R01 · FY2016 · CA
Histone Methyltransferases as a Target for Lung Cancer Prevention
$567,957Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2016 · CA
Resolution of Epithelial Cell Hyperplasia
$567,944Yohannes Tesfaigzi · Lovelace Biomedical & Environmental Research Institute · R01 · FY2012 · ES
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
$567,912Jie Wu · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA
PHAGOCYTOSIS--PULMONARY ALVEOLAR MACROPHAGES
$567,878Brigham And Women'S Hospital · R01 · FY2000 · HL
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
$567,838Mizuki Nishino · Brigham And Women'S Hospital · R01 · FY2020 · CA
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
$567,838Mizuki Nishino · Brigham And Women'S Hospital · R01 · FY2018 · CA
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
$567,838Mizuki Nishino · Brigham And Women'S Hospital · R01 · FY2021 · CA
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$567,760Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Follistatin-like 1 Mediated Host Defense in Bacterial Pneumonia
$567,734Brian T Campfield · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$567,683Alejandro V Villagra · Georgetown University · R01 · FY2024 · CA
SPATIAL PROFILING OF EARLY, OSIMERTINIB-RESISTANT BRAIN LESIONS IN EGFR-MUTANT LUNG CANCER MODELS
$567,654The Trustees Of Columbia University In The City Of New York · · FY2025 · Defense Health Agency
Modeling tumor-stroma crosstalk in lung cancer to identify targets for therapy
$567,645Stephen Tc Wong · Methodist Hospital Research Institute · U01 · FY2016 · CA
Research Project 1: Navigation and Artificial Intelligence Technology for Indigenous Virtual Education on smoking cessation (NAITIVE)
$567,642Jonathan B Bricker · Fred Hutchinson Cancer Center · U19 · FY2024 · MD
Support Services for the NHLBI-Sponsored Data Science Institutional Review Board
$567,624Laura Covington · The Emmes Company, Llc · OT2 · FY2019 · HL
Molecular mechanisms of SCLC initiation and detection in mice and humans
$567,542Mark A Krasnow · Stanford University · U01 · FY2021 · CA
Phone Enabled Implementation of Cessation Support (PHOENICS)
$567,527Ramzi George Salloum · University Of Florida · R01 · FY2022 · CA
CAREER: In Vitro Model Approaches Leveraging Quantitative Cancer Cell Properties as Determinants of Metastatic Potential
$567,520Cheryl Gomillion · University Of Georgia Research Foundation Inc · · FY2022 · ENG
Computing, Optimizing, and Evaluating Quantitative Cancer Imaging Biomarkers
$567,509Sandy A Napel · Stanford University · U01 · FY2019 · CA
Nicotine and Chronic Kidney Disease
$567,400Edgar A Jaimes · University Of Alabama At Birmingham · R01 · FY2009 · ES